Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zoetis Inc. ZTS

Healthcare  —  Drug Manufacturers Specialty & Generic
71.05 0.78 1.11% as of 25 Sep
Market cap
$29.2B
P/E
11.7×
S&P 500 Member Dividend Champion (10y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zoetis Inc. (ZTS) P/E ratio

As of 25 September 2026, Zoetis Inc. (ZTS) trades at a P/E ratio of 11.7×. Over the past ten years it has ranged from 11.6× (September 2026) to 70.6× (January 2016); the current reading is higher than 0% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 20.1× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 20.9× (29.82%)
FY2024 29.7× (23.31%)
FY2023 38.8× 19.07%
FY2022 32.6× (42.63%)
FY2021 56.8× 17.96%
FY2020 48.1× 14.14%
FY2019 42.1× 45.36%
FY2018 29.0× (28.89%)
FY2017 40.8× 25.55%
FY2016 32.5× (53.91%)

Quarterly

Period P/E ratio Change
Jun 2026 11.8× (39.61%)
Mar 2026 19.6× (6.20%)
Dec 2025 20.9× (15.29%)
Sep 2025 24.6× (8.07%)
42 more quarters

Against its own ten years

Low 11.6× High 70.6×
Ten-year median 38.1×
Current reading's percentile 0

P/E ratio against peers

Company P/E ratio
VTRS Viatris Inc. compare n/m
ELAN Elanco Animal Health Incorporated compare n/m
ZTS Zoetis Inc. 11.7×
UTHR United Therapeutics Corporation compare 15.7×
NBIX Neurocrine Biosciences, Inc. compare 19.6×
HLN Haleon PLC Sponsored ADR compare 20.6×
TAK Takeda Pharmaceutical Co. compare 28.4×
RDY Dr. Reddy's Laboratories Ltd compare 30.8×
TEVA Teva Pharmaceutical Industries Ltd. compare 62.2×
Drug Manufacturers Specialty & Generic industry median 20.1×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ZTS